Experts shed light on coronavirus response and its implications for people with HIV
SEARCH study finds universal 'test and treat' reduces infant HIV
Long-acting capsid inhibitor GS-6207 confirms safety and antiviral activity
HIV vaccine that generates broadly neutralising antibodies passes first safety and proof-of-concept study in humans
Dolutegravir-based HIV treatment is the safest and most effective choice for pregnant women
Younger people with HIV lose lung function faster
One third of adolescents and young adults on ART in Kenya are not virally suppressed
No increase in HIV in blood donations since rules for gay men were relaxed
New PEP studies revive interest in post-exposure prevention
